VF
CODX

Virtu Financial’s Co-Diagnostics CODX Stock Holding History

Virtu Financial’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,217
Closed -$44K – 1755
2025
Q3 		$44K Buy
4,217
+3,363
+394% +$31.3K ﹤0.01% 1152
2025
Q2 		$7K Sell
854
-954
-53% -$8.92K ﹤0.01% 1337
2025
Q1 		$17K Buy
+1,808
New +$34.6K ﹤0.01% 1122
2024
Q4 		– Sell
-368
Closed -$14K – 1616
2024
Q3 		$14K Sell
368
-562
-60% -$21.6K ﹤0.01% 1159
2024
Q2 		$35K Buy
+930
New +$33.8K ﹤0.01% 952
2023
Q2 		– Sell
-525
Closed -$23K – 1593
2023
Q1 		$23K Sell
525
-2
-0.4% -$160 ﹤0.01% 1221
2022
Q4 		$40K Buy
+527
New +$49.3K 0.01% 1119
2021
Q2 		– Sell
-1,660
Closed -$475K – 1583
2021
Q1 		$475K Buy
1,660
+795
+92% +$317K 0.03% 543
2020
Q4 		$241K Buy
+865
New +$320K 0.03% 758
2020
Q3 		– Sell
-2,286
Closed -$1.33M – 1131
2020
Q2 		$1.33M Buy
+2,286
New +$1.04M 0.15% 143
2019
Q4 		$34K Buy
+1,250
New +$36.9K ﹤0.01% 1261

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's CODX Position: Q4 2025 in Review

Virtu Financial sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 4,217 shares — an estimated $44K sold.

Virtu Financial first reported a position in CODX in Q4 2019 and held it in 11 quarters. The position peaked at $1.33M in Q2 2020. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Virtu Financial reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 4,217 Co-Diagnostics shares in Q4 2025, an estimated $44K.
  • Virtu Financial first reported a position in Co-Diagnostics in Q4 2019 and held it in 11 quarters.
  • Virtu Financial's Co-Diagnostics position peaked at $1.33M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.